Article Information
PubMed
Published By
History
- Received May 30, 2024
- Revision received November 18, 2024
- Accepted November 21, 2024
- First published December 2, 2024.
Copyright & Usage
Copyright © 2024 the authors SfN exclusive license.
Author Information
- Jian Chen1,*,
- Lan Yang1,2,*,
- Jinhuang Shen1,*,
- Jingshan Lu2,3,
- Xiaona Mo1,
- Linyi Huang1,
- Li Chen1,2, and
- Changxi Yu1,2
- 1Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350122, China
- 2Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350122, China
- 3Fujian Center for Safety Evaluation of New Drug, Fujian Medical University, Fuzhou, Fujian 350122, China
- Correspondence should be addressed to Changxi Yu at changxiyu{at}mail.fjmu.edu.cn or Li Chen at lichen01005{at}163.com.
Author contributions
Author contributions: J.C., L.Y., L.C., and C.Y. designed research; J.C., L.Y., J.S., J.L., X.M., and L.H. performed research; J.C., L.Y., and J.S. analyzed data; J.C. wrote the first draft of the paper; J.C., L.Y., L.C., and C.Y. edited the paper; J.C. wrote the paper.
Disclosures
The authors declare no competing financial interests.
Supported by National Natural Science Foundation of China (Grant/Award Numbers: 82373847, 81973309 to C.Y.) and Fujian Medical University Startup Fund for Scientific Research (Grant/Award Numbers: 2022QH2028 to J.C.).
↵*J.C., L.Y., and J.S. contributed equally to this work.
Funding
National Natural Science Foundation of China
82373847; 81973309Fujian Medical University Startup Fund for Scientific Research
2022QH2028